[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate

C37H41F3N8O5S — CID 134302059

IUPAC[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate
SMILESCc1c(Cc2c(CN3CCC(OC(=O)c4ccccc4)CC3)nc3c(-c4cn(S(=O)(=O)N(C)C)cn4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F
InChIInChI=1S/C37H41F3N8O5S/c1-25-27(10-7-11-30(25)37(38,39)40)20-33-32(22-45-14-12-28(13-15-45)53-36(49)26-8-5-4-6-9-26)42-35-29(31-23-47(24-41-31)54(50,51)44(2)3)21-34(43-48(33)35)46-16-18-52-19-17-46/h4-11,21,23-24,28H,12-20,22H2,1-3H3
InChIKeyWPKRYDHTTFZVPB-UHFFFAOYSA-N
MW766.85 g/mol
LogP4.82
Rot. Bonds10

About [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate

[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate (PubChem CID 134302059) has the molecular formula C37H41F3N8O5S and a molecular weight of 766.85 g/mol. Its IUPAC name is [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate.

Molecular Properties

Compound Name[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate
PubChem CID134302059
Molecular FormulaC37H41F3N8O5S
Molecular Weight766.85 g/mol
Exact Mass766.29
IUPAC Name[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate
SMILESCc1c(Cc2c(CN3CCC(OC(=O)c4ccccc4)CC3)nc3c(-c4cn(S(=O)(=O)N(C)C)cn4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F
InChIInChI=1S/C37H41F3N8O5S/c1-25-27(10-7-11-30(25)37(38,39)40)20-33-32(22-45-14-12-28(13-15-45)53-36(49)26-8-5-4-6-9-26)42-35-29(31-23-47(24-41-31)54(50,51)44(2)3)21-34(43-48(33)35)46-16-18-52-19-17-46/h4-11,21,23-24,28H,12-20,22H2,1-3H3
InChIKeyWPKRYDHTTFZVPB-UHFFFAOYSA-N
XLogP4.82
TPSA127.40 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms54
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500766.85
LogP ≤ 54.82
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Analyze [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate?
The IUPAC name of [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate (CID 134302059) is [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate.
What is the SMILES notation for [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate?
The canonical SMILES for [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate is Cc1c(Cc2c(CN3CCC(OC(=O)c4ccccc4)CC3)nc3c(-c4cn(S(=O)(=O)N(C)C)cn4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F.
What is the InChIKey of [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate?
The InChIKey is WPKRYDHTTFZVPB-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H41F3N8O5S/c1-25-27(10-7-11-30(25)37(38,39)40)20-33-32(22-45-14-12-28(13-15-45)53-36(49)26-8-5-4-6-9-26)42-35-29(31-23-47(24-41-31)54(50,51)44(2)3)21-34(43-48(33)35)46-16-18-52-19-17-46/h4-11,21,23-24,28H,12-20,22H2,1-3H3.
What are the key properties of [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate?
[1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate has a molecular weight of 766.85 g/mol, XLogP of 4.82, 10 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[[8-[1-(dimethylsulfamoyl)imidazol-4-yl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-2-yl]methyl]piperidin-4-yl] benzoate is sourced from PubChem (CID 134302059), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).